Rocuronium
- Generic Name
- Rocuronium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C32H53N2O4
- CAS Number
- 143558-00-3
- Unique Ingredient Identifier
- WRE554RFEZ
- Background
Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, ro...
- Indication
For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
- Associated Conditions
- Muscle fasciculation caused by succinylcholine
- Associated Therapies
- Curarization therapy, Neuromuscular blocking therapy, Facilitation of small bowel intubation therapy
Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel
- Conditions
- Interventions
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Larissa University Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT03596060
- Locations
- 🇬🇷
Larissa University Hospital, Larissa, Greece
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
- Conditions
- Interventions
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03572413
- Locations
- 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
Pharmacokinetics of Rocuronium for Deep Block (DeepRocu)
- Conditions
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2018-06-04
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Target Recruit Count
- 250
- Registration Number
- NCT03545308
- Locations
- 🇫🇷
CHU Nimes, Nîmes, Gard, France
Opioid-Free Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- OrthoCarolina Research Institute, Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT03540030
- Locations
- 🇺🇸
OrthoCarolina Research Institute, Charlotte, North Carolina, United States
QLB After Nephrectomy
- Conditions
- Interventions
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Medical University of Lublin
- Target Recruit Count
- 105
- Registration Number
- NCT03529201
- Locations
- 🇵🇱
Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów, Rzeszów, Poland
🇵🇱Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok, Białystok, Poland
Muscle Relaxants on Efficacy of LMA Insertion
- Conditions
- Interventions
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2019-10-25
- Lead Sponsor
- Daegu Catholic University Medical Center
- Target Recruit Count
- 128
- Registration Number
- NCT03487003
- Locations
- 🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of
Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application
- Conditions
- Interventions
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2018-06-13
- Lead Sponsor
- TC Erciyes University
- Target Recruit Count
- 96
- Registration Number
- NCT03424356
- Locations
- 🇹🇷
Erciyes University, Kayseri, Turkey
Effect of Intraoperative Neuromuscular Blockade on Postoperative Sore Throat and Hoarseness
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2019-12-20
- Lead Sponsor
- SMG-SNU Boramae Medical Center
- Target Recruit Count
- 117
- Registration Number
- NCT03397797
- Locations
- 🇰🇷
Jee-Eun Chang, Seoul, Korea, Republic of
Effect of NMBA on Surgical Conditions in THR
- Conditions
- Interventions
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2019-03-12
- Lead Sponsor
- Algemeen Ziekenhuis Maria Middelares
- Registration Number
- NCT03369782
- Locations
- 🇧🇪
AZ Maria Middelares, Gent, Oost-Vlaanderen, Belgium
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 344
- Registration Number
- NCT03346057
- Locations
- 🇺🇸
Mission Hospital - Memorial ( Site 1016), Asheville, North Carolina, United States
🇺🇸Cleveland Clin Foundation ( Site 1032), Cleveland, Ohio, United States
🇺🇸Hermann Drive Surgical Center ( Site 1021), Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.